Page 1 of Clinical Trials for Cancer and Leukemia Group B [SPONSOR-COLLABORATORS], 359 Total Matches
- 1CompletedLast Updated: August 3, 2011Condition(s): Colorectal Cancer
- 2Active, not recruitingLast Updated: April 10, 2012Condition(s): Breast Cancer
- 3CompletedLast Updated: March 2, 2011Condition(s): Lung Cancer
- 4TerminatedLast Updated: March 2, 2011Condition(s): Esophageal Cancer
- 5CompletedLast Updated: March 15, 2012Condition(s): Metastatic Cancer
- 6Active, not recruitingLast Updated: April 10, 2012Condition(s): Esophageal Cancer; Gastric Cancer
- 7CompletedLast Updated: March 31, 2011Condition(s): Colorectal Cancer
- 8Active, not recruitingLast Updated: March 15, 2012Condition(s): Leukemia
- 9Active, not recruitingLast Updated: March 15, 2012Condition(s): Breast Cancer
- 10CompletedLow, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerLast Updated: March 22, 2011Condition(s): Prostate Cancer
- 11Active, not recruitingLast Updated: March 15, 2012Condition(s): Kidney Cancer
- 12TerminatedLast Updated: August 1, 2011Condition(s): Leukemia
- 13Active, not recruitingLast Updated: March 15, 2012Condition(s): Prostate Cancer
- 14Active, not recruitingLast Updated: April 11, 2011Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
- 15Active, not recruitingLast Updated: June 21, 2011Condition(s): Prostate Cancer
- 16Active, not recruitingLast Updated: June 21, 2011Condition(s): Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma; Plasma Cell Neoplasm; Myelodysplastic Syndromes; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell Tumor
- 17CompletedLast Updated: March 15, 2012Condition(s): Lung Cancer
- 18CompletedLast Updated: March 17, 2011Condition(s): Lung Cancer
- 19Active, not recruitingLast Updated: April 10, 2012Condition(s): Leukemia
- 20Active, not recruitingLast Updated: March 15, 2012Condition(s): Multiple Myeloma; Plasma Cell Neoplasm
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Cancer+and+Leukemia+Group+B
